CTI BioPharma
CTIC
#5622
Rank
NZ$2.07 B
Marketcap
NZ$15.73
Share price
0.00%
Change (1 day)
33.17%
Change (1 year)

CTI BioPharma (CTIC) - Total assets

Total assets on the balance sheet as of March 2023 : NZ$0.19 Billion

According to CTI BioPharma 's latest financial reports the company's total assets are NZ$0.19 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

CTI BioPharma - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2022-12-31NZ$0.19 B87.03%
2021-12-31NZ$0.10 B31.38%
2020-12-31NZ$80.71 M17.46%
2019-12-31NZ$68.71 M-48.69%
2018-12-31NZ$0.13 B73.29%
2017-12-31NZ$77.28 M-16.15%
2016-12-31NZ$92.16 M-56.29%
2015-12-31NZ$0.21 B79.04%
2014-12-31NZ$0.11 B3.27%
2013-12-31NZ$0.11 B27.28%
2012-12-31NZ$89.6 M12.36%
2011-12-31NZ$79.74 M14.8%
2010-12-31NZ$69.46 M-27.5%
2009-12-31NZ$95.81 M-13.45%
2008-12-31NZ$0.11 B15.35%
2007-12-31NZ$95.97 M-33.6%
2006-12-31NZ$0.14 B-36.45%
2005-12-31NZ$0.22 B-12.28%
2004-12-31NZ$0.25 B15.36%
2003-12-31NZ$0.22 B-37.03%
2002-12-31NZ$0.35 B-51.21%
2001-12-31NZ$0.73 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
NZ$156.03 B 80,188.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$167.71 B 86,198.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$10.95 B 5,538.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$36.46 B 18,664.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$198.95 B 102,271.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$68.99 B 35,399.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$185.71 B 95,461.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland